Natixis »

Contineum Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2026-06-30 $144k 9.1k 15.87

More positions owned by Natixis

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors (TSLA)
Spdr Series Trust St Str P500etf (SPYM)
Energy Transfer Com Ut Ltd Ptn (ET)
Broadcom (AVGO)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)

View all positions for Natixis

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Jupiter Topco
Henderson Group
BlackRock
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Vanguard Capital Management
Perceptive Advisors
FMR
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners
Ikarian Capital
Sectoral Asset Management

View all funds holding Contineum Therapeutics